PR Newswire
LONDON, Feb. 23, 2026
LONDON, Feb. 23, 2026 /PRNewswire/ — The «Orthopedic Power Tools Market – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032» report has been added to the offering of Credence Research Inc.
https://mma.prnewswire.com/media/2562161/5819235/Credence_Research_Logo.jpg
The Orthopedic Power Tools Market is projected to grow from USD 1,741.77 million in 2024 to USD 2,275.91 million by 2032, at a CAGR of 3.40%. Growth is supported by rising orthopedic procedure volumes, rapid technology upgrades, and a strong push toward minimally invasive and robot-assisted surgery.
Browse 350+ market data Tables and 60 Figures spread through 370 Pages and in-depth TOC on «Orthopedic Power Tools Market»
Key Takeaways
- Steady rise in orthopedic cases, driven by aging populations and trauma, continues to expand procedure volumes worldwide.
- Advanced surgical techniques, including navigation and robotics, increase demand for precise, high-performance power tool systems.
- Technology upgrades focus on ergonomics, battery performance, connectivity, and compatibility with robotic and navigation platforms.
- North America holds about 40% market share, while Europe accounts for roughly 30%; Asia Pacific is the fastest-growing region.
- The market is moderately to highly concentrated, led by players such as Stryker, Zimmer Biomet, Johnson & Johnson Services, Inc., and B. Braun Melsungen AG.
Scope & Segmentation – Orthopedic Power Tools Market
The report offers detailed market sizing and forecasts for 2025-2032, mapping demand by product type, modality, technology, end-user, and geography. It examines adoption of minimally invasive surgery, robotic workflows, and smart instrument ecosystems.
Based on Product:
- Small Bone Orthopedic Power Tools
- Large Bone Orthopedic Power Tools
- High-Speed Orthopedic Power Tools
Based on Modality:
- Single-Use Orthopedic Power Tools
- Reusable Orthopedic Power Tools
Based on Technology:
- Pneumatic-Powered Systems
- Electric-Powered Systems
- Battery-Powered Systems
Based on End-User:
- Hospitals
- Ambulatory Surgical Centers
- Orthopedic Clinics
Based on Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Access crucial information at unmatched prices!
Request your sample report today and start making informed decisions powered by Credence Research Inc.
Rising Surgical Burden and Technology-Driven Precision Strengthen Demand for Orthopedic Power Tools
The orthopedic power tools market gains momentum from the growing burden of osteoarthritis, fractures, and spine disorders that require surgical care. Aging populations increase rates of degenerative joint disease and fragility fractures, raising demand for fixation, joint reconstruction, and spine procedures. In countries such as Saudi Arabia, higher trauma cases and a larger elderly base expand surgical volumes. Hospitals respond by adopting efficient and durable tools that support rising operating room workloads.
Rapid adoption of minimally invasive, navigation-assisted, and robot-enabled procedures further drives demand. These approaches require tools that deliver high precision, low vibration, and steady power within narrow surgical fields. Hospitals prefer integrated systems that connect drills, saws, and reamers with navigation and robotic platforms. This integration improves implant alignment, enhances workflow speed, and supports consistent surgical outcomes.
Technology upgrades continue to reshape product design and performance. Minimally invasive instruments support 25% shorter recovery times and offer up to 50% greater precision than traditional tools. Robotics integration improves surgical accuracy by nearly 20%, while smart devices provide real-time feedback in many procedures. Enhanced ergonomics reduce surgeon fatigue by about 30%, which can increase efficiency by roughly 15%. These improvements reduce complications, shorten hospital stays, and strengthen demand in high-volume orthopedic centers.
Stringent Regulatory Environment
The orthopedic power tools market operates under strict regulatory control. New products must pass demanding safety and performance tests, which extend development timelines and increase costs. Complex documentation and validation requirements can delay launches and create high entry barriers for smaller firms.
Manufacturers must also maintain robust post-market surveillance and quality systems. Any design changes or new features often require additional regulatory review. These factors push companies to build strong regulatory capabilities and invest continuously in compliance and quality management.
High Research and Development Costs
Continuous innovation requires heavy R&D investment. Companies must develop lighter, more powerful, and more connected tools that work seamlessly with robotic systems and digital platforms. Rapid technology cycles raise risks, as products may need frequent updates to remain competitive.
Smaller players can struggle with these costs, especially when competing against global brands with large R&D budgets. Price pressure from hospitals and group purchasing organizations adds another challenge, forcing firms to balance innovation with strict cost control.
Regional Growth Reflects Procedure Volumes and Technology Adoption
North America
North America is the dominant region, with about 40% of global market share. The United States leads due to high healthcare spending, a large elderly population, and strong adoption of minimally invasive and robotic orthopedic procedures. Advanced hospital infrastructure and active clinical research programs support early use of new power tool platforms.
Canada also contributes meaningfully through its universal healthcare system and growing investment in advanced orthopedic services. The region’s strong base of global manufacturers and innovation centers further supports development and commercialization of new technologies.
Europe and Asia Pacific
Europe holds around 30% of the market, supported by well-established healthcare systems and rising incidence of osteoarthritis and osteoporosis. Germany, the UK, and France lead adoption, backed by strict safety standards and strong focus on patient outcomes.
Asia Pacific is the fastest-growing region. Markets such as China, Japan, and India are upgrading hospital infrastructure and increasing access to complex orthopedic surgery. Rising incomes, more sports injuries, and expanding private hospital networks boost demand for advanced power tools and minimally invasive solutions.
Key Player Analysis
- Stryker
- Conmed Corporation
- Zimmer Biomet
- Medtronic
- AlloTech Co. LTD
- Kaiser Medical Technology
- NSK/NAKANISHI
- Johnson & Johnson Services, Inc.
- B. Braun Melsungen AG
- De Soutter Medical
These companies span North America, Europe, and Asia, using regional strengths to support global supply chains, service networks, and innovation pipelines.
Competitive Analysis
The orthopedic power tools market is highly competitive, with leading companies setting benchmarks for performance and reliability. Stryker focuses on innovation and broad portfolios, offering systems that improve surgical precision and streamline workflows in joint and trauma surgery. Zimmer Biomet invests heavily in R&D and integrates its power tools tightly with implant and robotic platforms.
Johnson & Johnson Services, Inc. leverages its global scale to expand across key orthopedic segments and drive adoption in mature and emerging markets. European players such as B. Braun Melsungen AG and De Soutter Medical add strong regional competition, with specialized tools and integrated solutions. Asian firms, including NSK/NAKANISHI and AlloTech Co. LTD, strengthen the supply base with high-precision systems. This mix of global and regional manufacturers accelerates product development and keeps pricing and service offerings competitive.
Recent Developments
- March 2025: Johnson & Johnson MedTech introduced the VELYS Robotic-Assisted Solution for unicompartmental knee arthroplasty. The launch expands VELYS beyond total knee replacements and strengthens its robotic portfolio in joint reconstruction.
- March 2025: Zimmer Biomet presented key orthopedic innovations at the American Academy of Orthopaedic Surgeons 2025 Annual Meeting. The company featured the Z1 Triple-Taper Femoral Hip System and the HAMMR Automated Hip Impaction System.
- March 10-14, 2025: At the AAOS 2025 Annual Meeting in San Diego, California, Johnson & Johnson MedTech showcased new digital orthopaedic solutions. The company highlighted advanced implants, refined surgical techniques, and data-driven technologies across joint reconstruction, trauma, extremities, and spine care.
- March 2025: Zydus Lifesciences acquired an 85.6% stake in Amplitude Surgical for EUR 256.8 million (about USD 280 million). The deal marks Zydus’ strategic expansion into the global medical technology sector.
- February 2025: Stryker launched the next-generation SurgiCount+ sponge management system. The system improves surgical safety and workflow in orthopedic procedures.
- January 2025: Stryker reported strong performance driven by new product launches and its Mako orthopedic surgical robot platform.
- February 2025: Zimmer Biomet received FDA clearance for the ROSA® Shoulder System. The system expands its ROSA® Robotics portfolio, which includes knee and hip applications.
- January 2024: Paragon 28 launched the FJ2000 Power Console and Burr System for minimally invasive foot and ankle procedures.
- January 2024: Arthrex introduced NanoExperience.com, an educational platform focused on Nano arthroscopy techniques.
Report Coverage
The research report offers an in-depth analysis based on Product, Modality, Technology, End-User, and Geography. It profiles leading players, outlining their business overview, product lines, investments, revenue focus, and key applications. The study reviews the competitive landscape, SWOT positioning, main drivers and restraints, as well as major market trends.
The report also examines regulatory conditions, technology shifts, and macroeconomic factors affecting growth. Scenario analysis highlights potential risks and opportunities across regions and customer segments. Finally, it provides strategic recommendations for new entrants and established companies seeking to expand within the Orthopedic Power Tools Market.
Browse The Full Report Here –
Related Reports published by Credence Research-
Orthopedic Artificial Discs Market
Orthopedic Orthotic Devices Market
Orthopedic Biomaterials Market
Orthopedic Soft Tissue Repair Market
Orthopedic Support Systems Market
Orthopedic Imaging Equipment Market
Orthopedic Digit Implants Market
Orthopedic Braces and Supports Market
Orthopedic Surgical Robots Market
Orthopedic Padding Market
Orthopedic Software Market
Orthopedic Splints Market
Orthopedic Contract Manufacturing Market
Orthopedic Devices Market
About Us
Credence Research Inc is a global market intelligence and consulting firm founded in 2015. It delivers deep market insights, quantitative analysis, and strategic guidance to business leaders, investors, governments, NGOs, and non-profit groups worldwide. The company helps organizations evaluate markets, understand trends, reduce risk, and make data-driven decisions that support growth and competitive strategy. Credence Research is known for rigorous research methods and comprehensive analytics.
The firm produces detailed reports covering market size, forecasts, growth drivers, trends, and competitive landscapes across many industries. Each report often includes frameworks like PESTLE and Porter’s Five Forces to give a complete view of market dynamics and future potential. Credence Research also provides tailored consulting services, due diligence support, go-to-market planning, and pre-IPO research to strengthen client strategies and investment narratives. Its insights come from both primary and secondary research, expert interviews, and advanced data modelling. The firm’s client base spans Europe, the Americas, Asia-Pacific, and the Middle East/Africa.
To find out more, visit www.credenceresearch.com or follow us on X.com, LinkedIn and Facebook.
Contact Us -Credence Research Inc,Tower C-1105, S 25,Akash Tower,Vishal Nagar,Pimple Nilakh, Haveli,Pune – 411027, IndiaUSA: +1-888-600-6441Email: [email protected] Our Website: https://www.credenceresearch.com/
Logo – https://mma.prnewswire.com/media/2562161/5819235/Credence_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/orthopedic-power-tools-market-to-reach-usd-2-275-91-million-by-2032-on-back-of-robotics-and-minimally-invasive-surgery-adoption–credence-research-inc-302694862.html
Tengo varias preguntas sobre esto a ver si me podiais aclarar:
-¿Puedo hacer un ingreso regular de 800 euros y me cobran 0euos de comisiones y mto.?
-¿Puedo sacar el dinero cuando quiera?,¿todo ó tengo entendido que hay que mantener un mínimo de 100 euros los 30 meses?
-No necesito pero me obligan a sacar una tarjeta de débito que me cuesta 11 euros el primer año y 22 euros la renovación, también otra de credito que me cuesta 0 euros el primer año y 35 euros la renovación.
¿Hay que mantenerlas 13 meses?
¿Puedo cancelar alguna de ellas desde el principio?
¿Puedo cancelar alguna de ellas antes de la renovación?
¿Hay alguna tarjeta de credito más barata?
Aparte de la cuenta nómina he visto que también que para que te den la tv también se puede sacar una cuenta tarifa plana básica o personal, ¿sabeis algo de estas cuentas?¿que requisitos tienen?
Muchas gracias a todos por responder
Yo fui a informarme y te cuento. Únicamente admiten los ingresos regulares en el caso de que seas autónomo. Te abren una cuenta Tarifa Plana Cero que está exenta de comisiones y presenta alguna ventaja más. Sobre dejar un mínimo de saldo en la cuenta no es necesario, pero sí te obligan a mantener varias tarjetas durante los 30 meses con un coste aproximado de 100 euros anuales.
hola buenas!
me llamo javi y estoy dudando de que banco, me puede dar mas beficios, sin sorpresas por domiciliar la nomina, ya que llevo años en la caixa y no me da nada ningun beneficio. es mas me rechazan los prestamos que solicito, ni siquiera una targeta de credito, por alegan de que siempre esta a cero la cuenta, yo cuando cobro la nomina dejo el dinero para los pagos, y saco el resto, pues no me fio, de que un dia me quede sin dinero, ya que esta todo muy mal, corre riesgo mi dinero o mis ahorros en el banco?? muchas gracias y un cordial saludo.
javi
NO TE EXTRAÑE QUE NO TE DEN LOS PTMOS, PORQUE LO QUE VEN ES QUE NO TIENES CAPACIDAD DE AHORRO PORQUE SIEMPRE DEJAS LA CTA. EN MINIMOS, ASI NINGUN BANCO TE LO VA A CONCEDER. TAMBIEN ES VERDAD QUE LA CAIXA, COMO TANTAS OTRAS CAJAS, TIENE EL PUÑO CERRADO PARA LOS RIESGOS, PARA REMONTAR. NO TE PREOCUPES, QUE POR UNA NOMINA NO CREO QUE NINGUN BANCO SE COJA LAS MANOS. LOS QUE SE TIENEN QUE PREOCUPAR SON LOS QUE TIENEN DÉPÓSITOS Y FONDOS EN BANCOS DE DUDOSA ACTIVIDAD. LA GENTE SE PIENSA QUE PORQUE LES DEN UN 7% YA ES UN GRAN BANCO Y SE EQUIVOCAN. LO QUE LES PASA ES QUE EL BANCO DE ESPAÑA LES PRESTA EL DINERO MAS CARO Y POR ESO OPTAN POR CONSEGUIRLO EN EL MERCADO MONETARIO, Y SI EL BANCO DE ESPAÑA NO SE FIA DE ELLOS, VA Y SE FIA LA GENTE. QUE LOS BANCOS NOES LA ADMON PUBLICA, ABRAN OS OJOS.
Hola , cuando vallais al banco queos dejen lo que hay que pagar de irpf y de iva sobre el valor de la tele ya que en la mayoria de bancos esto no lo dicen y luego llagan las sorpresas .A mi ya me ha pasado con la promoción del portatil y nunca me hablaros de esto . Cuidado
Yo he estado calculando y la tele entre unas cosas y otras te sale sobre unos 250euros que tampoco regalan tanto .Hay oficinas en las que han dado la occión de poner un dinero a plazo fijo a 12meses de 9300euros o 6800euros a 18 meses.
No es ningún chollo. Te obligan a contratar dos tarjetas de crédito que tienes que pagar porque las tienes que mantener 13 meses por lo menos y además llevan unos costes desproporcionados si las utilizas. En total, no usando las tarjetas y anulándolas una vez cumplidos los 13 meses puedes ahorrar unos 38 euros con respecto al precio de ese televisor en una gran superficie. Y además luego vendrá que te cobran para hacienda la retención correspondiente, por lo que probablemente incluso en las mejores condiciones te cueste más que si ahorras un poco y lña compras directamente.
Creó que teneis toda la razón, que aqui no te regalan nada, ya que a mí me paso con unas sartenes que regalaban el banco bilbao, que al final entre el irpf y el descuento de Hacienda, al final me salieron caras, así es que no os tomen el pelo, que al final siempre esta la letra pequeña que es la que nos joroba, por no decir otra cosa.
Yo saque el portatil y ahora me he sacado la TV LCD 32. Estas promos no hay que declararlas. No es obligado domiciliar nomina. Si, meter en la cuenta 800€ todos los meses en un margen de 10 dias. Cero matacero, pero cero,cero, cero de gastos de mantenimiento, ni por recibos, ni por el correo a casa, ni por transfer. Las tarjets gratis el 1er año. Resto fuera. Dadas de baja Menos la de debito. Banesto no pierde nada, ganar, gana clientes que es el proposito de esta promo. Precio de portatil y tv 32 en mercao unos 900€ los 2. En banest 197€. Los hay mejores, nos ha jodio! portatiles a 1200€, TV LCD 32 a 1000€. Señores, son lentejas. Relacion calida-precio-promo es cojonud…….Un saludit a los viandantes.
hola , no se si llegara mi comentario pero os voi a esplicar. esto es el cuento de la abuela. mira yo tengo el portatil. y he cogio tab la tele, pero sabeis ke?, me ha pasado de todo. os esplico. primero me cobran 74 euros y 25 euros de unas tarjetas que yo no las he visto aparecer por mi casa , me cabreo con el banco. llamo y pido esplicaciones. me dicen que van en la promocion, nunca jamas nadie me informo de las tarjetas, no me devuelven el dinero. me cabreo y me dicen que llame aun numero de tefono para darlas de baja, se pasan los dias, intentamos darlas de baja. largas y larga, que si este numero de tefono que si el otro bla bla bla. conseguimos hablar y nos dicen que tenemos que cambiar el contrato a tarifa plana o no se ke historias, llamando al banco se pasan los dias, largas y largas. me cabreo y estoi por suspender todo, me dicen que si lo quiero cambiar y dar de baja las tarjetas que nunca he tenido. tengo que pagar comisiones cada seis meses de doce y pico euros, y que si no quiero que me cobren comisiones tengo que ir todos los meses al banco a hacerlo yo, ufffffffffff.aun hay mas. me dan de baja y me hacen la tarifa plana, se equivocan un monton de veces. me hacen pasar muchos cabreos.y al final cuando llego a casa me han cobrado 25, 50 euros. y llamo por telefono y se lo digo , me dicen claro por dar de baja la otra cuenta , la madre que los pario. ladrones. o sea os digo que la tele no sale regalada, se la cobran y muy bien cobrada , nadie da nada por nada. en cuento termine de pagar lo que debo quito todas las cuentas del banesto.espero que alguien me lea y que me conteste gracias .
Banesto ha jodido a mi marido y a un amigo tambien. Para mi, despues de Banco de Andalucía son los peores. Y quieran creerlo o no ni la television ni el portátil te lo regalan.. como no cumplas cualquiera de las reglas te sancionan con 300 y pico de euros.. porque nos hemos mudado de casa y los recibos domiciados se cortaron «temporalmente» la sancion fue de mas de 300 euros.. y el cabreo q te llevas cuando ves lo q te han descontado y luego para ir a reclamarlos.. y como te tratan !! en fin.. espero que Banesto sea lo primero en undirse en el fin del mundo!!
CHOLLO!!!!!!!!!JAJAJAJAJA…….NO ES NINGUN CHOLLO!!!!!!! te cobran 100 € de gastos de manipulacion, mas 150 € en tarjetas durante 2 años, mas 6 € mensuales de mantenimiento de cuenta durante 30 meses, total que pagas 630 Euros por un ordenador o una TV que su valor seguro que no llega a 500 €. Y encima si vas a cancelar la cuenta cuando cumples los 30 meses requeridos te hacen esperar dos horas para decirte que no tienen linea de telefono para dar de baja la cuenta, cosa que no para nunca cuando vas a contratarlo. Y del trato que dispensan….., es el mismo que si vas con un fajo de billetes de 500 € por los CO-JONES
Banesto «premia», menuda falacia…
No hay ningún banco que premie a nadie.
BANESTO NECESITA NUESTRAS NÓMINAS, Y EN CUANTO VAS UN POCO JUSTO, COMO BUENOS JUDÍOS Y ÁVAROS QUE SON, TE ACOSAN Y MACHACAN, Y TE SACAN HASTA LAS ENTRAÑAS EN COMISIONES.
DESPUÉS EL ESTADO APOYA A LOS BANCOS, CON LA EXCUSA DE QUE SI CAEN LOS BANCOS CAEMOS TODOS. LOS BANCOS NECESITAN UN BOICOT DE VEZ EN CUANDO, PARA QUE NO NOS RESTREGUEN POR LA CARA SUS BENEFICIOS.
POR CIERTO, LO QUE MÁS FASTIDIA A UN BANCO ES UNA RECLAMACIÓN EN LA OFICINA DEL CONSUMIDOR Y OTRA AL BANCO DE ESPAÑA.
ES POR DAR PISTAS…